Antiserotonin treatment of hyperprolactinemic amenorrhea: long-term follow-up with metergoline, methysergide, and cyproheptadine. 1978

P G Crosignani, and M Peracchi, and G C Lombroso, and E Reschini, and A Mattei, and A Caccamo, and A D'Alberton

Twenty patients affected by hyperprolactinemic amenorrhea-galactorrhea have been treated with one or more of the following serotonin antagonists: metergoline, methysergide, and cyproheptadine. Among the 11 patients without evidence of pituitary tumor resumption of menses was observed in five, two of whom had ovulatory cycles; one patient became pregnant; ovulations occurred only during treatment with metergoline. In the group of nine patients with enlarged sellae, three experienced isolated episodes of bleeding, while two had three and four menses each, respectively; all cycles were anovulatory. Plasma prolactin levels and galactorrhea were favorably affected by treatment only in a minority of amenorrhea-galactorrhea patients with and without tumors.

UI MeSH Term Description Entries
D008711 Metergoline A dopamine agonist and serotonin antagonist. It has been used similarly to BROMOCRIPTINE as a dopamine agonist and also for MIGRAINE DISORDERS therapy. Methergoline,Liserdol
D008784 Methysergide An ergot derivative that is a congener of LYSERGIC ACID DIETHYLAMIDE. It antagonizes the effects of serotonin in blood vessels and gastrointestinal smooth muscle, but has few of the properties of other ergot alkaloids. Methysergide is used prophylactically in migraine and other vascular headaches and to antagonize serotonin in the carcinoid syndrome. Dimethylergometrin,Methylmethylergonovine,Deseril,Desril,Désernil-Sandoz,Methysergide Dimaleate,Methysergide Maleate,Sansert,UML-491,Dimaleate, Methysergide,Désernil Sandoz,Maleate, Methysergide,UML 491,UML491
D010911 Pituitary Neoplasms Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA. Pituitary Cancer,Cancer of Pituitary,Cancer of the Pituitary,Pituitary Adenoma,Pituitary Carcinoma,Pituitary Tumors,Adenoma, Pituitary,Adenomas, Pituitary,Cancer, Pituitary,Cancers, Pituitary,Carcinoma, Pituitary,Carcinomas, Pituitary,Neoplasm, Pituitary,Neoplasms, Pituitary,Pituitary Adenomas,Pituitary Cancers,Pituitary Carcinomas,Pituitary Neoplasm,Pituitary Tumor,Tumor, Pituitary,Tumors, Pituitary
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D003533 Cyproheptadine A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc. Antergan,Dihexazin,Periactin,Peritol,Viternum
D005260 Female Females
D005687 Galactorrhea Excessive or inappropriate LACTATION in females or males, and not necessarily related to PREGNANCY. Galactorrhea can occur either unilaterally or bilaterally, and be profuse or sparse. Its most common cause is HYPERPROLACTINEMIA. Galactorrheas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000568 Amenorrhea Absence of menstruation. Postpartum Amenorrhea,Amenorrhea, Postpartum,Postpartum Amenorrheas

Related Publications

P G Crosignani, and M Peracchi, and G C Lombroso, and E Reschini, and A Mattei, and A Caccamo, and A D'Alberton
February 1986, Obstetrics and gynecology,
P G Crosignani, and M Peracchi, and G C Lombroso, and E Reschini, and A Mattei, and A Caccamo, and A D'Alberton
January 1982, Gynecologic and obstetric investigation,
P G Crosignani, and M Peracchi, and G C Lombroso, and E Reschini, and A Mattei, and A Caccamo, and A D'Alberton
February 2001, Acta obstetricia et gynecologica Scandinavica,
P G Crosignani, and M Peracchi, and G C Lombroso, and E Reschini, and A Mattei, and A Caccamo, and A D'Alberton
November 1983, Fertility and sterility,
P G Crosignani, and M Peracchi, and G C Lombroso, and E Reschini, and A Mattei, and A Caccamo, and A D'Alberton
September 1979, Fertility and sterility,
P G Crosignani, and M Peracchi, and G C Lombroso, and E Reschini, and A Mattei, and A Caccamo, and A D'Alberton
January 1989, Neuropsychobiology,
P G Crosignani, and M Peracchi, and G C Lombroso, and E Reschini, and A Mattei, and A Caccamo, and A D'Alberton
January 1997, Medicina,
P G Crosignani, and M Peracchi, and G C Lombroso, and E Reschini, and A Mattei, and A Caccamo, and A D'Alberton
January 1995, Clinical and experimental obstetrics & gynecology,
P G Crosignani, and M Peracchi, and G C Lombroso, and E Reschini, and A Mattei, and A Caccamo, and A D'Alberton
February 2002, The Journal of clinical endocrinology and metabolism,
P G Crosignani, and M Peracchi, and G C Lombroso, and E Reschini, and A Mattei, and A Caccamo, and A D'Alberton
April 1981, Endocrinology,
Copied contents to your clipboard!